ES2068294T3 - 2,3-dihidro-1-(piridinilamino)-indoles, un procedimiento para su preparacion y su uso como medicamentos. - Google Patents

2,3-dihidro-1-(piridinilamino)-indoles, un procedimiento para su preparacion y su uso como medicamentos.

Info

Publication number
ES2068294T3
ES2068294T3 ES90114661T ES90114661T ES2068294T3 ES 2068294 T3 ES2068294 T3 ES 2068294T3 ES 90114661 T ES90114661 T ES 90114661T ES 90114661 T ES90114661 T ES 90114661T ES 2068294 T3 ES2068294 T3 ES 2068294T3
Authority
ES
Spain
Prior art keywords
loweralkyl
aryl
indoles
dihydro
arylloweralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90114661T
Other languages
English (en)
Inventor
Richard Charles Dr Effland
David Gordon Dr Wettlaufer
Joseph Thomas Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2068294T3 publication Critical patent/ES2068294T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

ESTA INVENCION ES RELTIVA A 2,3-DIHIDRO-1-(PIRIDINILAMINO)-INDOLOS DE LA FORMULA DONDE R1 ES HIDROGENO, ALQUILO INFERIOR, ARILO, ARILO ALQUILO INFERIOR, O HETEROARILO ALQUILO INFERIOR SELECCIONADO DEL GRUPO COMPUESTO POR PIRIDINILOMETILO, PIRIDINILOETILO, TIENILOMETILO, TIENILOETILO; R2 Y R3 SON INDEPENDIENTEMENTE HIDROGENO, ALQUILO INFERIOR, ARILO, ARILO ALQUILO INFERIOR, O HETEROARILO ALQUILO INFERIOR SELECCIONADO DEL GRUPO COMPUESTO POR PIRIDINILOMETILO, PIRIDINILOETILO, TIENILOMETILO, TIENILOETILO; O R2 Y R3 JUNTOS FORMAN UN ANILLO CICLOALCANO DE 4 A 6 CARBONOS O UN ARILO O HETEROCICLOALQUILO FUSIONADOS EN ESPIRAL; X E Y SON INDEPENDIENTEMENTE HIDROGENO, HALOGENO, HIDROXILO, ALQUILO INFERIOR, ALCOXILO INFERIOR, NITROGENO, AMINO O TRIFLUOROMETILO; M Y N SON INDEPENDIENTEMENTE ENTEROS DE 1 A 3. TAMBIEN ES RELATIVA A SUS SALES DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLES Y DONDE SON APROPIADAS LAS MEZCLAS OPTICAS, GEOMETRICAS Y ESTEREOISOMERAS Y RACEMICAS DE ELLAS Y A UN PROCESO PARA SU PREPARACION. LOS COMPUESTOS DE ESTA INVENCION PRESENTAN UTILIDAD COMO ANALGESICOS, ANTICONVULSIVOS, MEJORADORES DE MEMORIA Y PARA EL TRATAMIENTO DEL MAL DE ALZHEIMER.
ES90114661T 1989-08-02 1990-07-31 2,3-dihidro-1-(piridinilamino)-indoles, un procedimiento para su preparacion y su uso como medicamentos. Expired - Lifetime ES2068294T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38841589A 1989-08-02 1989-08-02

Publications (1)

Publication Number Publication Date
ES2068294T3 true ES2068294T3 (es) 1995-04-16

Family

ID=23534038

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90114661T Expired - Lifetime ES2068294T3 (es) 1989-08-02 1990-07-31 2,3-dihidro-1-(piridinilamino)-indoles, un procedimiento para su preparacion y su uso como medicamentos.

Country Status (17)

Country Link
EP (1) EP0415103B1 (es)
JP (1) JPH0674266B2 (es)
KR (1) KR0164595B1 (es)
AT (1) ATE118002T1 (es)
AU (1) AU628201B2 (es)
CA (1) CA2022488C (es)
DE (1) DE69016531T2 (es)
DK (1) DK0415103T3 (es)
ES (1) ES2068294T3 (es)
FI (1) FI95466C (es)
GR (1) GR3015228T3 (es)
IE (1) IE66601B1 (es)
IL (1) IL95251A (es)
NO (1) NO176398C (es)
NZ (1) NZ234726A (es)
PT (1) PT94880B (es)
ZA (1) ZA906048B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
US5214038A (en) * 1991-04-15 1993-05-25 Hoechst-Roussel Pharmaceuticals Inc. 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof
US5202319A (en) * 1991-09-23 1993-04-13 Hoechst-Roussel Pharmaceuticals Inc. Substituted 3-amino-2,3,4,5-tetrahydro-1-aryloxy-3-benzazepines
US5459274A (en) * 1994-05-13 1995-10-17 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
US6100276A (en) * 1996-04-12 2000-08-08 Aventis Pharmaceuticals Inc. Isatin derivatives as acetylcholinesterase inhibitors and analgesics
KR20000062358A (ko) * 1996-12-27 2000-10-25 게리 디. 스트리트, 스티븐 엘. 네스비트 알츠하이머병 및 울병 치료용 n-(피리디닐아미노)이소인돌린
GB0119435D0 (en) 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions
KR20230062158A (ko) 2021-10-29 2023-05-09 대우조선해양 주식회사 극지용 선박의 발전기 엔진의 외기 흡입구조 및 상기 외기 흡입구조를 포함하는 극지용 선박
KR20230062160A (ko) 2021-10-29 2023-05-09 대우조선해양 주식회사 극지용 선박의 공조 시스템 및 상기 극지용 선박의 외기 흡입구조
KR20230062159A (ko) 2021-10-29 2023-05-09 대우조선해양 주식회사 극지용 선박의 발전기 엔진의 외기 흡입구조 및 상기 외기 흡입구조를 포함하는 극지용 선박

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE115143T1 (de) * 1987-04-24 1994-12-15 Hoechst Roussel Pharma N-(pyridinyl)-1h-indol-1-amine, verfahren zu deren herstellung und ihre verwendung als arzneimittel.
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders

Also Published As

Publication number Publication date
AU6000390A (en) 1991-02-07
DE69016531D1 (de) 1995-03-16
ZA906048B (en) 1991-05-29
NO176398C (no) 1995-03-29
KR0164595B1 (ko) 1999-01-15
DK0415103T3 (da) 1995-06-19
FI95466C (fi) 1996-02-12
NO903390L (no) 1991-02-04
EP0415103B1 (en) 1995-02-01
GR3015228T3 (en) 1995-05-31
NO903390D0 (no) 1990-08-01
IE902788A1 (en) 1991-02-27
PT94880A (pt) 1991-04-18
PT94880B (pt) 1997-12-31
FI903820A0 (fi) 1990-07-31
NO176398B (no) 1994-12-19
AU628201B2 (en) 1992-09-10
DE69016531T2 (de) 1995-07-06
CA2022488C (en) 2000-11-07
CA2022488A1 (en) 1991-02-03
IL95251A (en) 1996-08-04
IE66601B1 (en) 1996-01-24
EP0415103A1 (en) 1991-03-06
IL95251A0 (en) 1991-06-10
FI95466B (fi) 1995-10-31
ATE118002T1 (de) 1995-02-15
NZ234726A (en) 1992-01-29
KR910004598A (ko) 1991-03-29
JPH0674266B2 (ja) 1994-09-21
JPH03118378A (ja) 1991-05-20

Similar Documents

Publication Publication Date Title
DK0415102T3 (da) 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-oner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ZA907033B (en) N-substituted-4-pyrimidinamines an pyrimidindiamines,a process for their preparation and their use as medicaments
HUT45503A (en) Process for producing alpha-alkyl-(4-amino-3-quinolinyl)-methanols, 1-/4-(aralkyl-amino)-3-quinolinyl/-alkanones and pharmaceutics comprising these compounds as active ingredient
ES2068294T3 (es) 2,3-dihidro-1-(piridinilamino)-indoles, un procedimiento para su preparacion y su uso como medicamentos.
DK0413191T3 (da) 1-(Pyridinylamino)-2-pyrrolidinoner, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
PT92234A (pt) Processo para a preparacao de 1,2,3,4-tetraidro-1,9-acridinodiaminas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 415103

Country of ref document: ES